SCHEMBL15948192

SCHEMBL15948192

O=C(O)Cc1c(F)c(F)c(CC(=O)O)c(F)c1F

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1B1 P15121 3/20 0.42
CA2 P00918 1/20 0.35
CAMK2A Q9UQM7 1/20 0.35
GAA P10253 3/20 0.34
KDM4E B2RXH2 2/20 0.34
ALDH1A1 P00352 2/20 0.34
GLA P06280 1/20 0.34
HPGD P15428 1/20 0.34
HSD17B10 Q99714 1/20 0.34
CSNK2A2 P19784 1/20 0.34
CSNK2B P67870 1/20 0.34
CSNK2A1 P68400 1/20 0.34
CSNK2A3 Q8NEV1 1/20 0.34
CYP1A2 P05177 2/20 0.33
AGBL2 Q5U5Z8 1/20 0.33
CXCL8 P10145 2/20 0.32
TAS1R3 Q7RTX0 1/20 0.32
TAS1R1 Q7RTX1 1/20 0.32
TAS1R2 Q8TE23 1/20 0.32
FOLH1 Q04609 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL503968 0.97 AKR1B1 (0.41) AKR1B1CA2CAMK2AGAAKDM4E
SCHEMBL15948146 0.94 AKR1B1 (0.39) AKR1B1CA2CAMK2AGAAKDM4E
SCHEMBL15948206 0.91 AKR1B1 (0.41) AKR1B1CA2CAMK2AGAAKDM4E
SCHEMBL11268242 0.87 CYP1A2 (0.37) AKR1B1CA2HSD17B10CYP1A2
SCHEMBL27762098 0.87 CSNK2A2 (0.41) AKR1B1CSNK2A2CSNK2BCSNK2A1CSNK2A3
SCHEMBL4103547 0.87 IMPDH2 (0.39) AKR1B1GAAKDM4EALDH1A1CYP1A2
SCHEMBL4674767 0.85 DUSP3 (0.35) AKR1B1FOLH1LMNAHTT
SCHEMBL29142080 0.83 SMN1; SMN2 (0.53) AKR1B1AGBL2TSHR
SCHEMBL12445751 0.82 CYP1A2 (0.37) AKR1B1GAAKDM4EALDH1A1GLA
SCHEMBL22344509 0.82 AKR1B1 (0.35) AKR1B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020124727-A1 SYNTHESIS METHOD FOR 2,3,5,6-TETRAFLUORO-4-METHOXYMETHYL BENZYL ALCOHOL 浙江中欣氟材股份有限公司 2020-06-25 WO disclosed
CN-109438234-B Synthetic method of 2,3,5, 6-tetrafluoro-4-methoxymethyl benzyl alcohol 浙江中欣氟材股份有限公司 2020-04-21 CN disclosed
US-8809451-B2 Fluorinated dicarboxylic acid derivative and polymer obtained therefrom CENTRAL GLASS COMPANY, LIMITED (JP) 2014-08-19 US disclosed
EP-2395040-A1 FLUORINATED DICARBOXYLIC ACID DERIVATIVE AND POLYMER OBTAINED THEREFROM Central Glass Company, Limited (JP) 2011-12-14 EP disclosed
US-20110301305-A1 Fluorinated Dicarboxylic Acid Derivative and Polymer Obtained Therefrom CENTRAL GLASS COMPANY, LIMITED (JP) 2011-12-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110301305-A1 Fluorinated Dicarboxylic Acid Derivative and Polymer Obtained Therefrom MCCC2, AFF2, F13A1 AKR1B1 2496/4885CA2 7/4885CAMK2A 2724/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.